Aytu BioPharma, Inc. (AYTU)
NASDAQ: AYTU · Real-Time Price · USD
2.550
-0.010 (-0.39%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Aytu BioPharma Analyst Ratings
Total Analysts
3
Consensus Rating
Strong Buy
Price Target
$9.33
Upside
+265.88%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $13 → $13 | Strong Buy | Maintains | $13 → $13 | +409.80% | Dec 10, 2025 |
| Maxim Group | Maxim Group | Strong Buy Maintains $9 → $7 | Strong Buy | Maintains | $9 → $7 | +174.51% | Sep 25, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $12 → $13 | Strong Buy | Maintains | $12 → $13 | +390.20% | Sep 25, 2025 |
| Lake Street | Lake Street | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +213.73% | Jul 1, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +370.59% | Jun 30, 2025 |
| Maxim Group | Maxim Group | Strong Buy Initiates $5 | Strong Buy | Initiates | $5 | +96.08% | Aug 9, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +684.31% | May 31, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $220 → $120 | Strong Buy | Maintains | $220 → $120 | +4,605.88% | Jul 21, 2022 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $220 → $100 | Buy | Maintains | $220 → $100 | +3,821.57% | May 17, 2022 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $480 → $220 | Strong Buy | Maintains | $480 → $220 | +8,527.45% | Apr 28, 2022 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $220 | Buy | Initiates | $220 | +8,527.45% | Mar 30, 2021 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $600 | Strong Buy | Initiates | $600 | +23,429.41% | May 29, 2020 |
| Northland Capital Markets | Northland Capital Markets | Buy Initiates $2,000 | Buy | Initiates | $2,000 | +78,331.37% | Oct 22, 2018 |